1-hydroxy-3-amino-pyrrolidone-2 (HA-966). IV. Clinical aspects.
D000342:Affective Symptoms / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D011760:Pyrrolidinones / Q000009:adverse effects / Q000627:therapeutic use*; D013118:Spinal Cord Diseases / Q000188:drug therapy*
D011760:Pyrrolidinones